Therapeutics: c-Met receptor tyrosine kinase (c-MET; MET; HGFR; c-Met proto-oncogene)

In vitro and mouse studies suggest the phenanthroindolizidine alkaloid (-)-antofine could help treat c-MET inhibitor-resistant cancers. In a c-MET inhibitor-resistant renal cell carcinoma (RCC) cell l...